| Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients M Ramos-Casals, R Solans, J Rosas, MT Camps, A Gil, ... Medicine 87 (4), 210-219, 2008 | 686 | 2008 |
| Churg–Strauss syndrome: outcome and long‐term follow‐up of 32 patients R Solans, JA Bosch, C Pérez‐Bocanegra, A Selva, P Huguet, J Alijotas, ... Rheumatology 40 (7), 763-771, 2001 | 361 | 2001 |
| Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient … R Seror, H Bootsma, A Saraux, SJ Bowman, E Theander, JG Brun, ... Annals of the rheumatic diseases 75 (2), 382-389, 2016 | 320 | 2016 |
| Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy R Solans, JA Bosch, P Galofré, F Porta, J Roselló, A Selva-O’Callagan, ... Journal of Nuclear Medicine 42 (5), 738-743, 2001 | 308 | 2001 |
| Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ... Annals of the rheumatic diseases 74 (5), 859-866, 2015 | 306 | 2015 |
| Systemic involvement in primary Sjögren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry) M Ramos-Casals, P Brito-Zeron, R Solans, MT Camps, A Casanovas, ... Rheumatology 53 (2), 321-331, 2014 | 268 | 2014 |
| Mortality and prognostic factors in Spanish patients with systemic sclerosis CP Simeon, L Armadans, V Fonollosa, R Solans, A Selva, M Villar, J Lima, ... Rheumatology 42 (1), 71-75, 2003 | 217 | 2003 |
| Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients P Brito-Zeron, B Kostov, R Solans, G Fraile, C Suárez-Cuervo, ... Annals of the rheumatic diseases 75 (2), 348-355, 2016 | 208 | 2016 |
| Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome R Solans-Laqué, A López-Hernandez, JA Bosch-Gil, A Palacios, ... Seminars in arthritis and rheumatism 41 (3), 415-423, 2011 | 195 | 2011 |
| A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility FD Carmona, SL Mackie, JE Martín, JC Taylor, A Vaglio, S Eyre, ... The American Journal of Human Genetics 96 (4), 565-580, 2015 | 188 | 2015 |
| Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. R Solans-Laque, JA Bosch-Gil, C Pérez-Bocanegra, A Selva-O'Callaghan, ... The Journal of rheumatology 35 (2), 294-304, 2008 | 188 | 2008 |
| Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data … P Brito-Zerón, N Acar-Denizli, M Zeher, A Rasmussen, R Seror, ... Annals of the rheumatic diseases 76 (6), 1042-1050, 2017 | 187 | 2017 |
| How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project) P Brito-Zerón, N Acar-Denizli, WF Ng, M Zeher, A Rasmussen, T Mandl, ... Clinical and experimental rheumatology 36 (3), S102-S112, 2018 | 176 | 2018 |
| Myositis‐specific and myositis‐associated antibodies in a series of eighty‐eight Mediterranean patients with idiopathic inflammatory myopathy A Selva‐O'Callaghan, M Labrador‐Horrillo, R Solans‐Laque, ... Arthritis Care & Research: Official Journal of the American College of …, 2006 | 170 | 2006 |
| Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients A Selva-O’Callaghan, M Labrador-Horrillo, X Munoz-Gall, ... Lupus 14 (7), 534-542, 2005 | 169 | 2005 |
| Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and … R Solans-Laqué, G Fraile, M Rodriguez-Carballeira, L Caminal, ... Medicine 96 (8), e6083, 2017 | 136 | 2017 |
| Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice M Calderón-Goercke, J Loricera, V Aldasoro, S Castañeda, I Villa, ... Seminars in arthritis and rheumatism 49 (1), 126-135, 2019 | 115 | 2019 |
| IgG4-related disease: results from a multicenter Spanish registry A Fernández-Codina, F Martínez-Valle, B Pinilla, C Lopez, I DeTorres, ... Medicine 94 (32), e1275, 2015 | 113 | 2015 |
| Central nervous system involvement of granulomatosis with polyangiitis: clinical–radiological presentation distinguishes different outcomes G De Luna, B Terrier, P Kaminsky, A Le Quellec, F Maurier, R Solans, ... Rheumatology 54 (3), 424-432, 2015 | 111 | 2015 |
| Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: Evidence of free radical–mediated injury R Solans, C Motta, R Solá, AE La Ville, J Lima, P Simeón, N Montellà, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 109 | 2000 |
